Eva Nedvedova

Eva Nedvedova is an experienced CMC manager at SOTIO since August 2018, specializing in the manufacturing of therapeutic protein candidates and ensuring quality and stability for pharmaceutical development. Previous experience includes roles as a Junior CMC manager and Scientist focused on preclinical development, where Eva conducted biochemical and in vitro testing, drug design, and compound purification. Prior to SOTIO, Eva worked as a PhD researcher at the Paul-Langerhans-Institute Dresden, studying protein-membrane interactions and coordinating interdisciplinary projects. Earlier experience includes an undergraduate researcher role at Charles University in Prague, investigating viral proteins, and a summer research position on cyanobacterial fungicidal agents. Eva holds a PhD in Membrane Biochemistry from Technische Universität Dresden and degrees in Genetics, Molecular Biology, and Virology from Charles University.